Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Ülke: Singapur

Dil: İngilizce

Kaynak: HSA (Health Sciences Authority)

Mevcut itibaren:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Sınıf:

Class D medical device

Tarafından üretildi:

Bio-Technology General (Israel) Ltd.

Terapötik alanı:

Orthopaedics

Terapötik endikasyonlar:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Ürün özeti:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Yetkilendirme tarihi:

2017-04-28